Skip to main content
Equibles
AVNS logo

AVNS · Avanos Medical, Inc.

Track AVNS — free

Use AVNS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about AVNS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$24.99 +0.01 (+0.04%) At close · Jul 24
Market Cap
$1.17B
Shares
46.82M

Avanos Medical, Inc. Earnings Call Transcripts

Every quarterly earnings call for Avanos Medical, Inc. (AVNS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼8.3% $170.90M $12.50M '22 Q2 22-08-09 ▼6.4% $172.30M $15.70M '22 Q3 22-11-02 ▲300.8% $143.50M $16.90M '22 Q4 23-02-21 ▼19.3% $159.30M −$500,000 '23 Q1 23-05-03 ▼0.9% $169.40M −$68.10M '23 Q2 23-08-09 ▼0.6% $171.30M −$3.70M '23 Q3 23-11-01 ▲20.8% $173.30M $10.50M '23 Q4 24-02-20 ▲4.3% $166.10M −$900,000 '24 Q1 24-05-02 ▲1.4% $171.70M $1.80M '24 Q2 24-07-31 ▼0.5% $170.40M $4.30M '24 Q3 24-10-30 ▲3.6% $179.60M −$397.30M '24 Q4 25-02-26 ▲0.8% $167.50M $6.60M '25 Q1 25-05-06 ▲1.9% $175.00M −$76.80M '25 Q2 25-08-05 ▲4.3% $177.80M −$1.40M '25 Q3 25-11-05 ▲0.7% $180.90M −$1.30M '25 Q4 26-02-24 LATEST ▲8.8% $182.20M $5.10M '26 Q1 26-05-05
Earnings call
FY26 · Q1
2026-05-05
Avanos Medical, Inc. Q1 FY2026 Earnings Call
Revenue
$182.20M
▲ 8.8% YoY
Diluted EPS
$0.11
▼ 21.4% YoY
Gross margin
51.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Avanos Medical, Inc. Q4 FY2025 Earnings Call
Positive tone Tariff mitigation and China exit Portfolio shaping (divestitures and M&A) 2026 financial guidance and outlook
Revenue
$180.90M*
▲ 0.7% YoY
Gross margin
47.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Avanos Medical, Inc. Q3 FY2025 Earnings Call
Confident tone Specialty Nutrition Systems growth Tariff mitigation and China exit Portfolio management and M&A
Revenue
$177.80M
▲ 4.3% YoY
Diluted EPS
$-0.03
▼ 133.3% YoY
Gross margin
48.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
Avanos Medical, Inc. Q2 FY2025 Earnings Call
Positive tone Pain Management and Recovery portfolio Tariffs and macroeconomic uncertainty Specialty Nutrition Systems growth
Revenue
$175.00M
▲ 1.9% YoY
Diluted EPS
$-1.66
▼ 4250% YoY
Gross margin
52.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
Avanos Medical, Inc. Q1 FY2025 Earnings Call
Positive tone Tariffs and macro risk Specialty Nutrition Systems growth Leadership transition
Revenue
$167.50M
▲ 0.8% YoY
Diluted EPS
$0.14
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-26
Avanos Medical, Inc. Q4 FY2024 Earnings Call
Positive tone Enteral Feeding / Specialty Nutrition Systems Pain Management and Recovery Portfolio Liquidity, Free Cash Flow, and Capital Allocation
Revenue
$179.60M*
▲ 3.6% YoY
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Avanos Medical, Inc. Q3 FY2024 Earnings Call
Balanced tone Leadership transition Digestive Health performance Game Ready growth
Revenue
$170.40M
▼ 0.5% YoY
Diluted EPS
$0.09
Gross margin
54.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
Avanos Medical, Inc. Q2 FY2024 Earnings Call
Confident tone Pain Management and Recovery portfolio Digestive Health performance Transformation priorities and 2025 targets
Revenue
$171.70M
▲ 1.4% YoY
Diluted EPS
$0.04
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Avanos Medical, Inc. Q1 FY2024 Earnings Call
Positive tone Transformation priorities / cost / margin Pain Management and Recovery portfolio Digestive Health / NeoMed / ENFit
Revenue
$166.10M
▲ 4.3% YoY
Diluted EPS
$-0.02
Gross margin
57.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Avanos Medical, Inc. Q4 FY2023 Earnings Call
Cautious tone IVP / RF and Game Ready performance M&A and portfolio optimization 2024 guidance and outlook
Revenue
$173.30M*
▲ 20.8% YoY
Gross margin
54.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Avanos Medical, Inc. Q3 FY2023 Earnings Call
Revenue
$171.30M
▼ 0.6% YoY
Diluted EPS
$-0.08
▼ 124.2% YoY
Gross margin
55.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Avanos Medical, Inc. Q2 FY2023 Earnings Call
Revenue
$169.40M
▼ 0.9% YoY
Diluted EPS
$-1.46
▼ 661.5% YoY
Gross margin
57.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Avanos Medical, Inc. Q1 FY2023 Earnings Call
Revenue
$159.30M
▼ 19.3% YoY
Diluted EPS
$-0.01
▼ 109.1% YoY
Gross margin
57.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
Avanos Medical, Inc. Q4 FY2022 Earnings Call
Revenue
$143.50M*
▲ 300.8% YoY
Gross margin
59.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Avanos Medical, Inc. Q3 FY2022 Earnings Call
Revenue
$172.30M
▼ 6.4% YoY
Diluted EPS
$0.33
Gross margin
58.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Avanos Medical, Inc. Q2 FY2022 Earnings Call
Revenue
$170.90M
▼ 8.3% YoY
Diluted EPS
$0.26
▼ 67.1% YoY
Gross margin
59.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-04
Avanos Medical, Inc. Q1 FY2022 Earnings Call
Revenue
$197.40M
▲ 9.2% YoY
Diluted EPS
$0.11
Gross margin
54.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Avanos Medical, Inc. Q4 FY2021 Earnings Call
Revenue
$35.80M*
▼ 80.6% YoY
Gross margin
89.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Avanos Medical, Inc. Q3 FY2021 Earnings Call
Revenue
$184.10M
▼ 0.9% YoY
Diluted EPS
$-0.73
▼ 282.5% YoY
Gross margin
49.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Avanos Medical, Inc. Q2 FY2021 Earnings Call
Revenue
$186.40M
▲ 13.9% YoY
Diluted EPS
$0.79
Gross margin
46.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-07
Avanos Medical, Inc. Q1 FY2021 Earnings Call
Revenue
$180.70M
▲ 0.2% YoY
Diluted EPS
$-0.17
▼ 312.5% YoY
Gross margin
50.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-18
Avanos Medical, Inc. Q4 FY2020 Earnings Call
Revenue
$185.00M*
▼ 2.5% YoY
Gross margin
46.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-03
Avanos Medical, Inc. Q3 FY2020 Earnings Call
Revenue
$185.70M
▲ 8.3% YoY
Diluted EPS
$0.40
Gross margin
51.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Avanos Medical, Inc. Q2 FY2020 Earnings Call
Revenue
$163.70M
▼ 4.9% YoY
Diluted EPS
$-0.06
Gross margin
52.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Avanos Medical, Inc. Q1 FY2020 Earnings Call
Revenue
$180.40M
▲ 9.9% YoY
Diluted EPS
$0.08
Gross margin
56.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
Avanos Medical, Inc. Q4 FY2019 Earnings Call
Revenue
$189.80M*
▲ 11.7% YoY
Gross margin
57.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–26 of 26 earnings calls
Key facts CIK 1606498 CUSIP 05350V106 13F (30d) 257 filings 254 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)